Corrine Savill - 11 Feb 2022 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role: Acting Chief Business Officer
Signature: /s/ Jeffrey Trigilio, Attorney-in-Fact
Issuer symbol: CGEM
Transactions as of: 11 Feb 2022
Transactions value $: $0
Form type: 4
Filing time: 15 Feb 2022, 15:43:58 UTC
Next filing: 12 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGEM	Common Stock	Award	$0	+16,500	+8.5%	$0	209,615	11 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGEM	Stock Option (Right to Buy)	Award	$0	+33,000		$0	33,000	11 Feb 2022	Common Stock	33,000	$13.6	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
F2	The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.